Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2024. The report specifically details a transaction in the company's own shares executed on August 6, 2024, under a share buyback programme announced on August 1, 2024.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses exclusively on share repurchase activity:
- Shares Purchased: 679,810 ordinary shares
- Highest Price Paid: 368.70 pence per share
- Lowest Price Paid: 360.10 pence per share
- Volume Weighted Average Price: 364.8339 pence per share
- Post-Transaction Share Capital: 9,130,507,715 ordinary shares
Material Changes
The primary material change reported is the reduction in the company's registered share capital following the cancellation of the purchased shares. The filing does not provide comparative financial data against prior periods.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial performance, or discussion of risks and contingencies. It notes that the announcement does not constitute an offer or solicitation of an offer for securities in any jurisdiction.
Investor Verification Checklist
- Verify the total number of shares repurchased under the August 2024 Buyback Programme to date.
- Confirm the remaining authorized share buyback limit and the programme's end date.
- Review the full breakdown of individual trades available via the provided London Stock Exchange link.
- Check the company's website for updated investor relations materials regarding the buyback status.